|
NVO
|
Novo Nordisk A/S
|
US
|
NYSE
|
|
NVS
|
Novartis AG
|
US
|
NYSE
|
|
NXGN
|
Nextgen
|
IL
|
TA
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
US
|
NASDAQ
|
|
OFSA3
|
Ouro Fino Saúde Animal Participações S.A
|
BR
|
SA
|
|
OGI
|
Organigram Holdings Inc.
|
US
|
NASDAQ
|
|
OGN
|
Organon & Co.
|
US
|
NYSE
|
|
OMER
|
Omeros Corporation
|
US
|
NASDAQ
|
|
ON4
|
Ono Pharmaceutical Co. Ltd
|
DE
|
MU
|
|
ON4
|
ONO PHARMACEUT.
|
DE
|
F
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
OPNT
|
Opiant Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
OPTN
|
OptiNose, Inc.
|
US
|
NASDAQ
|
|
ORMP
|
Oramed Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
ORNBV
|
Orion Oyj B
|
FI
|
HE
|
|
ORX
|
Orexo AB
|
SE
|
ST
|
|
OTIC
|
Otonomy, Inc.
|
US
|
NASDAQ
|
|
OVB
|
Ovoca Bio Plc
|
UK
|
LSE
|
|
PAA
|
PharmAust Limited
|
AU
|
ASX
|
|
PAHC
|
Phibro Animal Health Corporation
|
US
|
NASDAQ
|